BACKGROUND:Periconception folate supplementation significantly reduces the risk of neural-tube defects, but few U.S. women start folate supplementation before pregnancy, and the amount of clinician time available to counsel patients about folate is limited. This study evaluated whether computer-assisted counseling and the provision of free folate tablets increases women's knowledge and use of folate supplements. DESIGN: Randomized controlled trial; follow-up began 6 months after enrollment and was completed on average 7 months after enrollment. SETTING/PARTICIPANTS: A total of 446 women, aged 18-45 years, were recruited from two urgent care clinics in San Francisco from March to July 2005 (data collection was completed in 2006; data were analyzed in 2007). INTERVENTION: Participants received a 15-minute computerized educational session and 200 folate tablets. MAIN OUTCOME MEASURES: The primary outcome was the knowledge that folate can prevent birth defects; secondary outcomes included the self-reported use of a folate supplement at follow-up. RESULTS: At follow-up, women in the intervention group were more likely to know that folate prevents birth defects (46% vs 27%, relative risk [RR]=1.72, 95% CI=1.32, 2.23); to know that folate is most important in early pregnancy (36% vs 17%, RR=2.11, 95% CI=1.50, 2.97); and to report the recent use of a folate supplement (32% vs 21%, RR=1.54, 95% CI=1.12, 2.13). CONCLUSIONS: A one-time, brief, computerized counseling session about folate with the provision of free folate tablets increased the knowledge and use of folate supplements among women > or =6 months later. TRIAL REGISTRATION: NCT00177515.
RCT Entities:
BACKGROUND:Periconceptionfolate supplementation significantly reduces the risk of neural-tube defects, but few U.S. women start folate supplementation before pregnancy, and the amount of clinician time available to counsel patients about folate is limited. This study evaluated whether computer-assisted counseling and the provision of free folate tablets increases women's knowledge and use of folate supplements. DESIGN: Randomized controlled trial; follow-up began 6 months after enrollment and was completed on average 7 months after enrollment. SETTING/PARTICIPANTS: A total of 446 women, aged 18-45 years, were recruited from two urgent care clinics in San Francisco from March to July 2005 (data collection was completed in 2006; data were analyzed in 2007). INTERVENTION: Participants received a 15-minute computerized educational session and 200 folate tablets. MAIN OUTCOME MEASURES: The primary outcome was the knowledge that folate can prevent birth defects; secondary outcomes included the self-reported use of a folate supplement at follow-up. RESULTS: At follow-up, women in the intervention group were more likely to know that folate prevents birth defects (46% vs 27%, relative risk [RR]=1.72, 95% CI=1.32, 2.23); to know that folate is most important in early pregnancy (36% vs 17%, RR=2.11, 95% CI=1.50, 2.97); and to report the recent use of a folate supplement (32% vs 21%, RR=1.54, 95% CI=1.12, 2.13). CONCLUSIONS: A one-time, brief, computerized counseling session about folate with the provision of free folate tablets increased the knowledge and use of folate supplements among women > or =6 months later. TRIAL REGISTRATION: NCT00177515.
Authors: James M Robbins; Mario A Cleves; H Breck Collins; Nancy Andrews; Laura N Smith; Charlotte A Hobbs Journal: Am J Obstet Gynecol Date: 2005-04 Impact factor: 8.661
Authors: Sabina de Weerd; Chris M G Thomas; Rolf J L M Cikot; Régine P M Steegers-Theunissen; Theo M de Boo; Eric A P Steegers Journal: Obstet Gynecol Date: 2002-01 Impact factor: 7.661
Authors: Kay Johnson; Samuel F Posner; Janis Biermann; José F Cordero; Hani K Atrash; Christopher S Parker; Sheree Boulet; Michele G Curtis Journal: MMWR Recomm Rep Date: 2006-04-21
Authors: Mario A Cleves; Charlotte A Hobbs; H Breck Collins; Nancy Andrews; Laura N Smith; James M Robbins Journal: Obstet Gynecol Date: 2004-04 Impact factor: 7.661
Authors: Jean M Lawrence; Margaret L Watkins; Daniel Ershoff; Diana B Petitti; Vicki Chiu; Debbie Postlethwaite; J David Erickson Journal: Am J Prev Med Date: 2003-07 Impact factor: 5.043
Authors: Aimee K Santucci; Melanie A Gold; Aletha Y Akers; Sonya Borrero; Eleanor Bimla Schwarz Journal: Birth Defects Res A Clin Mol Teratol Date: 2010-01
Authors: Eleanor B Schwarz; Elizabeth J Burch; Sara M Parisi; Kathleen P Tebb; Daniel Grossman; Ateev Mehrotra; Ralph Gonzales Journal: Contraception Date: 2012-08-24 Impact factor: 3.375
Authors: Sarah C Tinker; Owen Devine; Cara Mai; Heather C Hamner; Jennita Reefhuis; Suzanne M Gilboa; Nicole F Dowling; Margaret A Honein Journal: Birth Defects Res A Clin Mol Teratol Date: 2013-10